Latest Investment News

Talius Group reports a robust December quarter with $4.4 million revenue, positive operating cash flow, and a strategic $2.5 million capital raise, positioning the company for strong growth in 2025 amid evolving aged care legislation.

Santana Minerals has reported a robust Pre-feasibility Study for its Bendigo-Ophir Gold Project, lifting the after-tax NPV to A$1.2 billion and IRR to 76%, as it progresses detailed engineering and fast-track permitting in New Zealand.

Santos delivered a robust Q4 2024 with over US$1.4 billion in sales revenue and strong free cash flow, while progressing key LNG projects and expanding its decarbonisation initiatives.

Gryphon Capital Income Trust has announced an estimated ordinary dividend of AUD 0.0141 per unit for January 2025, payable in February. The distribution is unfranked and reflects the trust's ongoing income strategy.

Westgold Resources Limited achieved record gold production of 80,886 ounces in Q2 FY25, driving a robust net mine cash flow of $45 million and securing a $200 million corporate facility to fuel growth.

Fortescue Metals Group has delivered its highest ever half-year iron ore shipments of 97.1 million tonnes, alongside a notable 10% reduction in hematite production costs, underscoring operational strength and advancing decarbonisation efforts.

Parkway Corporate Limited reports a robust December quarter with a 420% revenue increase and key milestones in brine processing technology, positioning itself as a pivotal player in Queensland's CSG industry.

Condor Energy Ltd has raised A$3 million through a well-supported placement to advance its exploration and commercialisation efforts in the Tumbes Basin offshore Peru, focusing on the promising Piedra Redonda gas discovery.

EP&T Global delivered a positive net operating cash inflow of $0.4 million in the December 2024 quarter, supported by an 11% increase in customer receipts and a $1 million private placement to back expansion plans.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

Regal Investment Fund has updated its dividend announcement, confirming an actual ordinary dividend of AUD 0.10 per unit payable in March 2025. The distribution relates to the six-month period ending December 31, 2024.

Powerhouse Ventures Limited reports a robust quarterly performance with a notable uplift in net tangible assets to 10.4 cents per share, driven by strategic acquisitions and active investment management.